Publicaciones científicas sobre los diagnósticos no invasivos de BioPredictive

Estudios revisados por pares que validan los diagnósticos por análisis de sangre de BioPredictive para enfermedades hepáticas — desde cohortes de desarrollo pioneras hasta metaanálisis a largo plazo.

3/435 Coincidencias para
“granularity”

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication

Poynard T et al. · Diagnostics (Basel) · 2025 Coinc. 100

**Background/Objectives:** Bariatric surgery (BS), drugs approved for type-2-diabetes (T2D…

FibroTest-T2D Metabolic
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Poynard T et al. · Biomedicines · 2025 Coinc. 84

**Background:** The current definition of metabolic dysfunction-associated steatotic liver disease (MASLD…

FibroTest NashTest-2 SteatoTest-2 Metabolic
Noninvasive Assessment of Liver Fibrosis. Key publication Review

Castera L et al. · N Engl J Med · 2025 Coinc. 67

FibroTest Metabolic

Mostrando la lista completa de resultados. La página se renderiza en el servidor y no está paginada.

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Noninvasive Assessment of Liver Fibrosis. Key publication Review